All articles by GlobalData Healthcare

ATS 2026: PABPC4 gene identified as a key driver of emphysema in COPD

At the American Thoracic Society (ATS) 2026 annual meeting on 18 May, during the B109 cellular, genetics, and developmental drivers…
ATS 2026: Long-term data show durable benefit of Trikafta for cystic fibrosis

On 18 May, at the 2026 American Thoracic Society (ATS) international conference, during a poster session, a single-centre, observational cohort…
ECO 2026: indirect comparison favours Wegovy pill over Foundayo

On 15 May, at the 33rd European Congress on Obesity in Istanbul, Türkiye, findings from a post-hoc indirect treatment comparison…
ECO 2026: tirzepatide shows potential for T1D treatment

During the 2026 European Congress on Obesity (ECO) in Istanbul, a meta-analysis was presented analysing the use of tirzepatide, a…
ECO 2026: SURMOUNT-MAINTAIN proves tirzepatide sustains weight loss long term

On May 13, at the 33rd European Congress on Obesity in Istanbul, Türkiye, findings from the Phase III SURMOUNT-MAINTAIN trial…

ECO 2026: ATTAIN-MAINTAIN trial showcases orforglipron’s role in sustained weight loss

On 13 May, at the 33rd European Congress on Obesity in Istanbul, Türkiye, findings from the Phase 3b ATTAIN-MAINTAIN trial…
ECO 2026: gut hormone signals differ in T1D with obesity

At the 2026 European Congress on Obesity (ECO) in Istanbul, researchers presented a small observational study assessing fasting peptide YY…
ECO 2026: REDEFINE-1 demonstrates CagriSema’s improvement in body composition

On 12 May 2026, at the 33rd European Congress on Obesity in Istanbul, Türkiye, findings from the Phase 3a REDEFINE-1…
Thinning revenues: inside the $14bn Eliquis patent cliff

Eliquis (apixaban) is one of the most commercially consequential loss-of-exclusivity (LOE) events in recent pharmaceutical history, with patent expiries expected…
Early detection of bowel Cancer in the UK represents success of screening program

Bowel cancer, also known as colorectal cancer, is the second most lethal cancer after lung cancer, with the highest incidence…